GeneTex zebrafish antibodies

Thursday, 05 August, 2021 | Supplied by: Sapphire Bioscience

As a leading manufacturer of zebrafish antibodies, GeneTex offers an extensive portfolio of reagents validated for use in this model system.

The company currently offers a continuously expanding catalogue of reagents designed expressly for zebrafish research, with more than 300 newly developed zebrafish antibodies. These antibodies have been tested on zebrafish samples in a variety of applications including, but not limited to, immunofluorescence, immunohistochemistry and western blot.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022

GeneTex carrier-free antibodies

GeneTex's carrier-fee antibodies are BSA-, sodium azide- and glycerol-free, featuring diverse...

Cayman Chemical LipidLaunch Ionizable Lipid LNP Screening Set

The LipidLaunch Ionizable Lipid LNP Screening Set is a screening set of 12 ionisable cationic and...

Antibodies.com neutrophil marker antibodies

Antibodies.com offers a variety of markers that identify neutrophils at various stages of...

Content from other channels on our network

AMCS 2026: APAC Overview and Industry Insights with Michael Bates

Industry transitions from gas to renewable heat: report

Boral launches detailed carbon reporting capability

Study assesses recycled content use in home builds

Smart bin receives 2026 Australian Good Design Award

Burnout in health care isn't an 80/20 problem: why a more balanced view is needed and what it means for you and your workplace

A Good Cleaning Schedule: Best Practices for Healthcare Facilities

Conviction and $20K fine follows "serious and prolonged" offending by former podiatrist

Supagas acquires Heeson Medical

Why digital resilience is becoming critical in aged care

The roles of the vendor and EPCs in the project bidding process

ARC awards $82.5m for new research hubs and training centres

Industrial electricity costs could halve by sharing infrastructure

Seeq and Applied Computing partner on industrial AI for energy operations

ARENA opens Round 3 of Solar Sunshot with $250m available